true
Bloodstream Infection Solution
What if you had an integrated bloodstream infection (BSI) diagnostics solution that empowered you with actionable results to inform and impact patient care?
- Overview
- Educational Resources
The integrated, end-to-end Bloodstream Infection Solution brings together proven, quality solutions across the entire bloodstream infection diagnostic continuum — from world-class blood culture collection to accurate, timely and actionable results — helping you to optimize time, resources and decision-making to drive improved patient outcomes.
Diagnosis of bloodstream infections is challenging as time is of the essence and stakes are high
1.7 million sepsis cases are reported each year in the US, contributing to approximately a third of all hospital deaths.1-3 50% of septic patients in the ICU have bacteremia, which increases the risk of septic shock and death as compared to non-bacteremic sepsis.4,5 Blood cultures are an essential tool in the diagnostic workup of patients with signs of sepsis.
Although sepsis carries a high burden, it's estimated that about 80% of septic shock patients survive when appropriate antibiotic therapy is started within the first hour following onset of hypotension.6
What if you could quickly and accurately obtain actionable results to support faster antibiotic decision making and contribute to improving patient outcomes?
Consistently collect high-quality blood culture specimens
We offers world-class blood culture collection products that enable phlebotomy and nursing staff to collect the high-quality specimens that labs and clinicians need to make a timely diagnosis and appropriate treatment decisions.
First, the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set is designed to simplify the collection process, reduce perceived pain and accelerate fill times, ultimately improving the chance of collecting a high-quality specimen and enhancing the patient’s experience.7-11
Then, by adding the Magnolia Steripath® Initial Specimen Diversion Device®, you can achieve near-zero blood culture contamination rates.12-16
Improve time to microbial detection and organism recovery
The Bloodstream Infection Solution includes a complete line of blood culture media formulations and scalable, modular instrumentation that can be deployed near the point of collection to support faster time to incubation and reduced time to appropriate treatment.17-20
Combine the performance of the BD BACTEC™ perfect media pair with the scalable and modular BD BACTEC™ FX instrumentation to optimize the recovery of yeast, aerobic and anaerobic bacteria, for more accurate decision making and faster antimicrobial therapy initiation.17-22
Ensure accurate pathogen identification and extensive antibiotic coverage
The BD™ Bruker MALDI Biotyper® System offers high throughput capability and an extensive library for fast, robust and reliable identification of microorganisms.24-26
With an extensive panel format, true doubling dilutions, and extended breakpoints, the BD Phoenix™ Automated Identification and Antimicrobial Susceptibility Testing System marries performance with ease of use to provide timely and accurate detection of known and emerging antimicrobial resistance that supports your antimicrobial stewardship efforts.27-32
Access meaningful and actionable insights anytime, anywhere
Monitoring, analyzing and communicating microbiology data in a timely manner can directly impact patient care.33,34 However, obtaining, organizing and communicating this information is labor intensive
The BD informatics solutions empower you with actionable information and analytics that can be used to drive continuous improvement of blood collection practices and laboratory workflows, as well as the ability to communicate results in a timely manner to key stakeholders.18,34
Support faster initiation of optimal therapy and antimicrobial stewardship efforts
Delayed or inappropriate initial antimicrobial therapy for bloodstream infection results in prolonged hospital stays and increased mortality rates, while contributing to the silent pandemic of antimicrobial resistance.35-37
Find a Lab
Strive for clinical and operational excellence across the bloodstream infection diagnostic continuum
Our clinical solution
It can be difficult to identify the root cause of issues along the diagnostic pathway that may influence the quality of results. Without knowing where to make improvements, you won’t know where to invest time, resources or training. Furthermore, the bloodstream infection diagnostic pathway is complex and involves a great number of stakeholders.
The Clinical Specialists can help you quickly and easily gain insights across your current bloodstream infection diagnostic pathway by objectively understanding and quantifying challenges, risks and inefficiencies, along with giving you tailored solutions and recommendations to address your specific needs.
With the expertise of the Clinical Specialists
combined with the insights generated from BD Informatics, you’ll be empowered to...41,47
-
Reduce variability and inefficiencies
that create waste and risk
-
Establish greater accountability
by sharing insights and metrics
-
Maintain adherence to best practices
and potentially improve patient experience and outcomes
and potentially improve patient experience and outcomes
Unparalleled bloodstream infection solutions for clinicians, laboratories and operational teams each step along the bloodstream infection pathway
As your trusted partner, we are committed to helping you make sustainable clinical and economic impact through a holistic approach to bloodstream infection management. We do so by empowering your teams with tools and technologies that support quality, accuracy and efficiency improvements across all stages of the bloodstream infection diagnostic pathway.
ED nurses, phlebotomists
The Bloodstream Infection Solution, which includes the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set and the Magnolia Steripath® Initial Specimen Diversion Device®, empowers you to quickly and consistently fill blood culture bottles with near-zero blood culture contamination rates, giving you a better chance to collect the high-quality specimens that labs and clinicians need to make a timely diagnosis and appropriate treatment decisions8-16,34,39 — with the additional benefit of improved protection against accidental needlestick injuries.40,41
Laboratories
The integrated Bloodstream Infection Solution addresses all your BSI diagnostic needs — from specimen collection and blood culture to identification and susceptibility testing — with speed, accuracy and efficiency, and empowers you with actionable insights that can be used to drive continuous improvement of blood collection practices, minimize time to results and optimize resources.10,18,24,25,34,38,39
Sepsis coordinators
The integrated Bloodstream Infection Solution allows you to strengthen the connection between your laboratory and nursing stakeholders, establishing greater long-term accountability both inside and outside of the lab and ensuring that your teams can consistently and effectively adhere to blood culture collection and testing best practices.12,34,38
Infectious disease specialists
The combination of informatics and instruments as part of the Bloodstream Infection Solution helps you actively find ways to achieve and maintain the highest quality all along the bloodstream infection pathway. With our complementary identification and antimicrobial susceptibility testing instruments, you will be empowered to quickly and accurately translate actionable laboratory results into appropriate patient treatment and react to emerging resistance or healthcare-associated infection events.31,32,34,38
Hospital leaders
By connecting all the steps from specimen collection to results reporting, the integrated Bloodstream Infection Solution helps you drive antimicrobial stewardship, reduce hospital length of stay, make substantial savings and enhance your Centers for Medicare & Medicaid Services (CMS) key quality outcome metrics and reimbursement.15,18,31,32,42-45
-
Heritage
Through our purpose rooted in Advancing the World of Health™ for over 125 years, combined with over 40 years of experience in bloodstream infection diagnostics, we continue to be a pioneer in bloodstream infection diagnosis.
-
Innovation
We understand the challenges you face every day. As your partner, we are committed to continuously invest in innovation and help you elevate the standard of care for bloodstream infection diagnostics.
-
Partnership
We provide you with an unparalleled end-to-end bloodstream infection diagnostics solution thanks to our robust portfolio and our strategic partnerships with Magnolia Medical Technologies, Accelerate Diagnostics and Bruker.
BD Diagnostic Solutions is Now Waters Advanced Diagnostics
BD Diagnostic Solutions and Biosciences have combined with Waters Corporation to create a life sciences and diagnostics leader driven by innovation and a relentless commitment to our customers.
As we begin our new journey as part of Waters, there will be no immediate changes in how we serve you. The way you order your products and services and how you process payment for them will not change. Your points of contact for sales, customer service, technical service and support or clinical services will remain the same.
- CDC. What is Sepsis? Updated August 24, 2023. https://www.cdc.gov/sepsis/what-is-sepsis.html. Accessed August 31, 2023
- Rhee C et al. JAMA. 2017;318(13):1241–9
- Rhee C et al. JAMA Netw Open. 2019;2(2):e187571
- Mellhammar L et al. Sci Rep. 2021;11(1):6972
- Komori A et al. Sci Rep. 2020;10(1):2983
- Kumar A et al. Crit Care Med. 2006;34(6):1589–96
- Mouser A et al. J Appl Lab Med. 2017;2(2):201–10
- Merrill VD et al. J Appl Lab Med. 2022;7(2):532–40
- Padoan A et al. Clin Chim Acta. 2020;500:213–9
- BD Study Summary VS9249-2. 2021
- BD Study Summary VS9248-2. 2021
- Bell M et al. J Emerg Nurs. 2018;44(6):570–5
- Arenas M et al. J Emerg Nurs. 2021;47(2):256–64
- Zimmerman FS et al. Am J Infect Control. 2019;47(7):822–6
- Nielsen LE et al. J Hosp Infect. 2021;120:127–33
- Povroznik MD. Am J Med Qual. 2022;37(5):405–12
- Zadroga R et al. Clin Infect Dis. 2013;56(6):790–7
- Bruins MJ et al. Eur J Clin Microbiol Infect Dis. 2017;36(4):619–23
- Almuhayawi M et al. PLoS ONE. 2015;10(11):e0142398
- Rocchetti A et al. J Microbiol Methods. 2016;130:129–32
- Rohner P et al. J Clin Microbiol. 1997;35(10):2634–8
- Li G et al. Front Cell Infect Microbiol. 2019;9:285
- O'Neill J et al. "Tackling drug-resistant infections globally: Final report and recommendations" in the Review on Antimicrobial Resistance. 2016. https://amr-review.org/Publications.html. Accessed 22 Jun 2023
- Saffert RT et al. J Clin Microbiol. 2011;49(3):887–92
- Knabl L et al. Lett Appl Microbiol. 2021;73(1):2–8
- Watanabe N et al. J Infect Chemother. 2022;28(4):563–8
- BD Phoenix™ M50 Automated Microbiology System User's Manual (500008930)
- Carey RB et al. Failure of Automated Systems to Detect Vancomycin-Resistant Staphylococcus aureus. Abstract presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 2004
- Tenover FC et al. Emerg Infect Dis. 2006;12(8):1209–13
- Kulah C et al. BMC Infect Dis. 2009;9:30
- Mittman SA et al. J Clin Microbiol. 2009;47(11):3557–61
- Woodford N et al. J Clin Microbiol. 2010;48(8):2999–3002
- CDC. Preventing Adult Blood Culture Contamination: A Quality Tool for Clinical Laboratory Professionals. Available at: https://www.cdc.gov/labquality/docs/BCC-Prevention_A-Quality-Tool_CDC.pdf. Accessed October 2023
- Khare R et al. Clin Infect Dis. 2020;70(2):262–8
- Battle SE et al. J Antimicrob Chemother. 2017;72(1):299–304
- Burnham J et al. Open Forum Infect Dis. 2017 Oct 4;4(Suppl 1):S623–4
- Bauer KA et al. Open Forum Infect Dis. 2022;9(11):ofac537
- Lippi G et al. Clin Chem Lab Med. 2011;49(7):1113–26
- Garcia RA et al. Am J Infect Control. 2015;43(11):1222–37
- Hotaling M. Jt Comm J Qual Patient Saf. 2009;35(2):100–5
- Dicristina DL. Successfully reducing wingset-related needlestick injuries: A combination of institutional culture, staff commitment and semi-passive safety device. AOHP. Spring 2014. https://www.bd.com/resource.aspx?IDX=31023
- Geisler BP et al. J Hosp Infect. 2019;102(4):438–44
- Skoglund E et. J Clin Microbiol. 2019;57(1):e01015-18
- Self W et al. Infect Control Hosp Epidemiol. 2014;35(8):1021–8
- Tompkins LS et al. Infect Control Hosp Epidemiol. 2023;44(9):1386–90
Disclaimer:
This business has been acquired by Waters Corporation (“Waters”). For products referenced on this page, the legal manufacturer remains Becton, Dickinson and Company or one of its affiliates or subsidiaries (“BD”) until all required regulatory transfers are completed. During this interim period, BD maintains full responsibility for all regulatory obligations of the legal manufacturer. Product information provided here is supplied under the regulatory authority of BD. To learn more about the relationship between Waters and BD during this transition period, please see our detailed summary waters.com/bdtransaction.
true
